Akanda Corp.AKAN

NasdaqHealthcareMedicinal Chemicals & Botanical Products
Price (close)
$3.05
Market cap
—
P/E
—
Revenue (FY)
$836,664
Net income
-$4.1M
Dividend yield
—
1-year total return
-96.4%
Net margin
-489.6%
Revenue growth
97.5%
Debt / equity
—

What Akanda Corp. does.

to cannabis cultivation, manufacturing and distribution company. We have a limited operating history and minimal revenues to date. We

September 19, 2023, Akanda entered an option to purchase agreement for Canadian farming property in British Columbia, including related

operations and licenses, from 1107385. On September 22, 2023, Akanda entered an amended and restated purchase agreement with 1107385

Revenue and profit, by fiscal year.

Fiscal year201920202021202220232024
Revenue—$2,062$41,431$2.6M$423,683$836,664
Net income-$1.4M-$2.3M-$8.1M-$11.7M-$32.3M-$4.1M
Free cash flow——-$7.1M-$11.8M-$1.5M-$6.1M

More on AKAN.

Figures from Akanda Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.